搜索筛选:
搜索耗时0.0770秒,为你在为你在102,285,761篇论文里面共找到 10 篇相符的论文内容
发布年度:
[期刊论文] 作者：Chen-hua MA,Guo-dong LU,Jiong QIU,
来源：浙江大学学报（英文版）（C辑：计算机与电子） 年份：2010
...
,Adaptive robust neural control of a two-manipulator system holding a rigid object with inaccurate b
[期刊论文] 作者：Fan XU,Jin WANG,Guo-dong LU,
来源：信息与电子工程前沿（英文版） 年份：2018
The problem of self-tuning control with a two-manipulator system holding a rigid object in the presence of inaccurate translational base frame parameters is add...
[期刊论文] 作者：Yong LI,Jin WANG,Guo-dong LU,Guo-jun PAN,,
来源：Journal of Zhejiang University-Science A(Applied Physics & E 年份：2014
研究目的:验证无芯模旋压工艺可行性,同时深入探究此新型工艺机理,研究并获取旋轮轨迹曲线参数化控制及其对于零件成形精度的影响趋势。创新要点:基于贝塞尔曲线实现对于无芯...
[期刊论文] 作者：Jin WANG,Ting GE,Guo-dong LU,Fei LI,,
来源：Journal of Zhejiang University-Science A(Applied Physics & E 年份：2016
目的:探究错距旋压仿真模型关键特性参数影响,改进建模方法,克服现有模型方案的缺陷,构建更准确、可靠和稳定的错距旋压有限元仿真模型。创新点:1.提供包括全模型、六面体离...
[期刊论文] 作者：Hai GUO,Jin WANG,Guo-dong LU,Zi-han SANG,Qi-hang WANG,,
来源：Journal of Zhejiang University-Science A(Applied Physics & E 年份：2017
目的:通过优化无芯模旋压轨迹提高成形件形状精度,同时保持壁厚以防止过度减薄。创新点:针对轨迹形状设计,提出利于形状误差抑制的"几何相似性原则"和利于壁厚保持的"小曲率...
[期刊论文] 作者：Yu-lei GENG,Jin WANG,Guo-dong LU,Zheng LIU,Gang CHEN,
来源：浙江大学学报（英文版）（C辑：计算机与电子） 年份：2011
...
,High-Quality Large-Sized Single Crystals of Pb-Doped Bi2Sr2CuO6+δ High-Tc Superconductors Grown wit
[期刊论文] 作者：ZHAO Lin,ZHANG Wen-Tao,LIU Hai-Yun,MENG Jian-Qiao,LIU Guo-Dong,LU Wei,DONG Xiao-Li,ZHOU Xing-Jiang,
来源：中国物理快报（英文版） 年份：2010
...
,Varacin-1, a novel analog of varacin C, induces p53-independent apoptosis in cancer cells through R
[期刊论文] 作者：Jing Zhou,Wen-li Li,Zi-xuan Wang,Nai-yuan Chen,Yue Tang,Xiao-xiao Hu,Jing-huan Deng,Yixin Lu,Guo-dong Lu,
来源：中国药理学报（英文版） 年份：2019
Varacin C is a promising anticancer agent and possesses acid-promoted and photo-induced DNA-damaging activities.In this study,we synthesized an analog varacin-1...
[期刊论文] 作者：Deng,Zi-xuan Wang,Xiao-mei Yang,Yu-jia Liu,Yong Wu,Pan-hong Chen,Huan Shi,Ji-gang Wang,Jing Zhou,Guo-dong Lu,
来源：中国药理学报（英文版） 年份：2021
Sorafenib is the first-line medication for advanced hepatocellular carcinoma(HCC),but it can only extend limited survival.It is imperative to find a combination...
[期刊论文] 作者：,Hui-qi Dai,Pan-hong Chen,Zhong-jie Li,Wen-jing Su,Chuang-ye Han,Xin-ping Ye,Tao Peng,Jing Zhou,Guo-dong Lu,
来源：中国药理学报（英文版） 年份：2021
Sorafenib is the first-line treatment of advanced hepatocellular carcinoma(HCC).However,there is a lack of validated biomarkers to predict sorafenib sensitivity...
相关搜索：
